ASTH Astrana Health, Inc.
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.…
Industry Peers
Medical Care FacilitiesKey Statistics
About Astrana Health (NASDAQ: ASTH)
›
Astrana Health (NASDAQ: ASTH) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 3,000 employees.
The shares were at 28.90 USD on 20 November 2026, up 28.8% over 52 weeks. Its 52-week range is 18.08 USD to 51.59 USD: the price is 44.0% below the high and 59.8% above the low.
At a market capitalisation of 1.44B USD, it trades at 26.8 times trailing earnings and 8.3 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.8, a premium of 12% for ASTH.
Astrana Health reports return on equity of 2.9%, an operating margin of 2.6% and revenue up 7.1% year over year.
Its debt exceeds its cash by 581.16M USD, a debt-to-equity ratio of 1.38. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 9 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 51.89 USD is 79.5% above the current price. The next earnings report is expected on 1 March 2027.